|Bid||27.04 x 800|
|Ask||27.06 x 900|
|Day's Range||26.94 - 27.07|
|52 Week Range||15.92 - 28.17|
|Beta (5Y Monthly)||1.58|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar. 07, 2022 - Mar. 11, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||28.25|
Intersect ENT (XENT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Amid industry-wide concerns of deferral of elective procedures, Intersect ENT's (XENT) plans to consolidate with an industry behemoth like Medtronic seems a strategically aligned survival plan.
An increase in Intersect ENT's (XENT) operating costs puts pressure on its Q3 bottom line.